Medidata Solutions Inc (NASDAQ:MDSO) Shares Bought by Asset Management One Co. Ltd.

Share on StockTwits

Asset Management One Co. Ltd. raised its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 102.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,948 shares of the company’s stock after acquiring an additional 2,000 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Medidata Solutions were worth $248,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP boosted its stake in Medidata Solutions by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 130,588 shares of the company’s stock valued at $8,202,000 after acquiring an additional 663 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in Medidata Solutions by 4.0% in the first quarter. Municipal Employees Retirement System of Michigan now owns 18,400 shares of the company’s stock valued at $1,156,000 after acquiring an additional 710 shares during the last quarter. Meadow Creek Investment Management LLC boosted its stake in Medidata Solutions by 31.4% in the fourth quarter. Meadow Creek Investment Management LLC now owns 3,680 shares of the company’s stock valued at $233,000 after acquiring an additional 880 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Medidata Solutions by 48.3% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock valued at $205,000 after acquiring an additional 1,056 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its stake in Medidata Solutions by 8.9% in the first quarter. Thrivent Financial for Lutherans now owns 13,840 shares of the company’s stock valued at $869,000 after acquiring an additional 1,134 shares during the last quarter.

A number of research analysts have weighed in on MDSO shares. Piper Jaffray Companies boosted their target price on shares of Medidata Solutions to $98.00 and gave the company an “overweight” rating in a research note on Wednesday, May 23rd. Morgan Stanley reiterated an “equal weight” rating on shares of Medidata Solutions in a research note on Friday, June 1st. Deutsche Bank boosted their target price on shares of Medidata Solutions from $85.00 to $90.00 and gave the company a “buy” rating in a research note on Wednesday, June 13th. ValuEngine upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a research note on Thursday, April 12th. Finally, Zacks Investment Research cut shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Thursday, April 26th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $86.07.

In other Medidata Solutions news, EVP Michael I. Otner sold 10,395 shares of the stock in a transaction that occurred on Wednesday, April 25th. The shares were sold at an average price of $70.05, for a total value of $728,169.75. Following the sale, the executive vice president now directly owns 74,165 shares in the company, valued at approximately $5,195,258.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Rouven Bergmann sold 3,000 shares of the stock in a transaction that occurred on Tuesday, June 19th. The stock was sold at an average price of $82.85, for a total transaction of $248,550.00. Following the completion of the sale, the chief financial officer now owns 81,642 shares in the company, valued at $6,764,039.70. The disclosure for this sale can be found here. Insiders sold a total of 24,025 shares of company stock worth $1,774,961 over the last quarter. Corporate insiders own 4.70% of the company’s stock.

Shares of MDSO stock opened at $80.56 on Friday. The company has a market cap of $4.69 billion, a P/E ratio of 86.99, a price-to-earnings-growth ratio of 5.08 and a beta of 1.50. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.63 and a current ratio of 1.63. Medidata Solutions Inc has a 12 month low of $59.60 and a 12 month high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Thursday, April 19th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.05. Medidata Solutions had a net margin of 7.96% and a return on equity of 11.36%. The business had revenue of $149.20 million for the quarter, compared to analysts’ expectations of $146.73 million. During the same period in the prior year, the company posted $0.31 EPS. The business’s revenue for the quarter was up 16.9% compared to the same quarter last year. research analysts forecast that Medidata Solutions Inc will post 0.76 EPS for the current year.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply